Treatment of Uncontrolled Crying After Stroke

Drugs & Aging

Volumn 6, Issue 2, 1995, Pages 105-111

  Andersen, Grethe ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

ADULT; CASE REPORT; CEREBROVASCULAR DISEASE; CRYING; DEPRESSION; HUMAN; MALE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

CASE REPORT; CEREBROVASCULAR DISORDERS; CITALOPRAM; CRYING; DEPRESSION; HUMAN; MALE; MIDDLE AGE;

EID: 0029249693     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/00002512-199506020-00003     Document Type: Article

References (24)

1. Control of emotional expression in pseudobulbar palsy
2. Pathological laughter and crying
3. Treatment of pathological laughing and weeping with amitriptyline
4. Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study
5. Citalopram for post-stroke pathological crying
6. Pathologic laughing and crying treated with levodopa
7. Treatment of ‘emotional incontinence’ with levodopa
8. Fluoxetine improves emotional incontinence
9. Fluoxetine as a treatment for emotional lability after brain injury
10. Treatment of emotional lability with low-dosage tricyclic antidepressants
11. Emotionalism after stroke [letter]
12. The use of imipramine (‘Tofranil’) and other psychotropic drugs in organic emotionalism
13. Emotionalism after stroke
14. Emotionalism following brain damage: a complex phenomenon
15. Pathological display of affect in patients with depression and right frontal brain damage
16. Crying following stroke
17. Pathoanatomical correlation between post-stroke pathological crying and damage to serotonergic neurotransmission
18. Treating uncontrolled crying after stroke
19. Kinetics of citalopram in elderly patients
20. Pathologic laughter and crying in ALS: a search for their origin
21. Is the syndrome of pathological laughing and crying a manifestation of pseudobulbar palsy?
22. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance
23. Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram